Hemophilia Market Expected To Reach Highest CAGR By 2032
Global Hemophilia Market to Reach USD 21.24 Billion by 2032 Driven by Rising Prevalence and Breakthrough Therapies The global hemophilia market, valued at an estimated USD 13.84 billion in 2024, is projected to expand to USD 21.24 billion by 2032 at a CAGR of 5.5%, propelled by rising hemophilia prevalence, advancements in gene therapy, and increasing adoption of...
0 Comments 0 Shares 206 Views 0 Reviews
eekarnataka https://eekarnataka.com